INTERNATIONAL PATENT: FRIEDRICH-ALEXANDER-UNIVERSITAT ERLANGEN-NURNBERG, IN VERTRETUNG DES FREISTAATES BAYERN FILES APPLICATION FOR "A BISPECIFIC BINDING AGENT TARGETING CD3 AND BCMA FOR THE TREATMENT OF AUTOIMMUNE DISEASES"

GENEVA, Feb. 23 -- FRIEDRICH-ALEXANDER-UNIVERSITAT ERLANGEN-NURNBERG, IN VERTRETUNG DES FREISTAATES BAYERN (Freyeslebenstr. 191058 Erlangen) filed a patent application (PCT/EP2025/061451) for "A BISPECIFIC BINDING AGENT TARGETING CD3 AND BCMA FOR THE TREATMENT OF AUTOIMMUNE DISEASES" on Apr 25, 2025. With publication no. WO/2026/037514, the details related to the patent application was published on Feb 19, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): GRIESHABER-BOUYER, Ricardo (c/o FRIEDRICH-ALEXANDER-UNIVERSITAT ERLANGEN-NURNBERG, IN VERTRETUNG DES FREISTAATES BAYERNFreyeslebenstr. 19105...